Clinical Trial Update: Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3 [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating hypofractionated stereotactic irradiation for radio-resistant brain metastases, evolving from a D1-3-5 regimen to a D1-2-3 reg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Centre Paul Strauss | Conditions: Brain Metastases | Phase 3 | Status: NOT_YET_RECRUITING